Literature DB >> 12917632

Antisense overexpression of BMAL2 enhances cell proliferation.

Chau-Ting Yeh1, Su-Chuan Lu, I-Chu Tseng, Hsin-Yu Lai, Mei-Lin Tsao, Shiu-Feng Huang, Yun-Fan Liaw.   

Abstract

To identify genes that are frequently downregulated in hepatocellular carcinoma (HCC), a panel of putative underexpressed genes was first established by an in-house cDNA macroarray method. Two different assays, semiquantitative RT-PCR combined with Northern analysis and customized cDNA microarray analysis, were used to screen through these genes and the results were compared. Several genes, some with unknown function, were confirmed to be downregulated by both the methods. The effect of a downregulated gene, BMAL2, on cell proliferation was examined. Overexpression of antisense BMAL2 RNA in 293EBNA cells resulted in reduced cell cycle time, increased plating efficiency in soft agar, diminished TNF-alpha-induced increment of CPP32/caspase-3 activity, and a reduced proportion of cells in the G2 phase with a concomitantly increased proportion of cells in the S phase. In conclusion, by combining three different methods, we have obtained a panel of frequently down regulated genes in HCC, including BMAL2. Antisense overexpression of BMAL2 enhances cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12917632     DOI: 10.1038/sj.onc.1206674

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

1.  Inhibition of type 1 diabetes by upregulation of the circadian rhythm-related aryl hydrocarbon receptor nuclear translocator-like 2.

Authors:  Chen-Xia He; Nicolas Prevot; Christian Boitard; Philip Avner; Ute C Rogner
Journal:  Immunogenetics       Date:  2010-07-30       Impact factor: 2.846

2.  Widespread Dysregulation of Long Noncoding Genes Associated With Fatty Acid Metabolism, Cell Division, and Immune Response Gene Networks in Xenobiotic-exposed Rat Liver.

Authors:  Kritika Karri; David J Waxman
Journal:  Toxicol Sci       Date:  2020-04-01       Impact factor: 4.849

3.  ARNTL2 and SERPINE1: potential biomarkers for tumor aggressiveness in colorectal cancer.

Authors:  Gianluigi Mazzoccoli; Valerio Pazienza; Anna Panza; Maria Rosa Valvano; Giorgia Benegiamo; Manlio Vinciguerra; Angelo Andriulli; Ada Piepoli
Journal:  J Cancer Res Clin Oncol       Date:  2011-12-24       Impact factor: 4.553

Review 4.  Phenotypic effects of genetic variability in human clock genes on circadian and sleep parameters.

Authors:  Malcolm von Schantz
Journal:  J Genet       Date:  2008-12       Impact factor: 1.166

Review 5.  Microarray-based analysis for hepatocellular carcinoma: from gene expression profiling to new challenges.

Authors:  Yutaka Midorikawa; Masatoshi Makuuchi; Wei Tang; Hiroyuki Aburatani
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

Review 6.  Evolving roles of circadian rhythms in liver homeostasis and pathology.

Authors:  Dexi Zhou; Yaqin Wang; Lu Chen; Leijuan Jia; Jie Yuan; Mei Sun; Wen Zhang; Peipei Wang; Jian Zuo; Zhenyu Xu; Jiajie Luan
Journal:  Oncotarget       Date:  2016-02-23

7.  Upregulation of ARNTL2 is associated with poor survival and immune infiltration in clear cell renal cell carcinoma.

Authors:  Song Wang; Xueyou Ma; Yufan Ying; Jiazhu Sun; Zitong Yang; Jiangfeng Li; Ke Jin; Xiao Wang; Bo Xie; Xiangyi Zheng; Ben Liu; Liping Xie
Journal:  Cancer Cell Int       Date:  2021-07-03       Impact factor: 5.722

Review 8.  The Expression and Function of Circadian Rhythm Genes in Hepatocellular Carcinoma.

Authors:  Yanan Jiang; Xiuyun Shen; Moyondafoluwa Blessing Fasae; Fengnan Zhi; Lu Chai; Yue Ou; Hai Feng; Siwei Liu; Ying Liu; Shucai Yang
Journal:  Oxid Med Cell Longev       Date:  2021-10-16       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.